SYRA HEALTH CORP. Cash and Restricted Cash
SYRA HEALTH CORP. (SYRA) had Cash and Restricted Cash of $2.12 million as of 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.12M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.92M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.61M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.98M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $2.12M S-1 · filed 2026-09-14 | |
| 2026-03-31 | $2.92M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.61M S-1 · filed 2026-09-14 | |
| 2025-09-30 | $1.98M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.31M S-1 · filed 2026-09-14 | |
| 2025-03-31 | $2.49M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $2.40M S-1 · filed 2026-09-14 | |
| 2024-09-30 | $2.70M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.59M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $3.24M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $3.28M S-1 · filed 2026-09-14 | |
| 2023-09-30 | $18.01K 10-Q · filed 2024-10-29 | $18.01M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $36.45K 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $596.41K 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $3.34K 10-K · filed 2025-03-11 | $3.34M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $668.53M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $100.01K 10-K · filed 2024-03-25 | $100.01M 10-Q · filed 2023-11-14 |